Industry & Policy News

[STAT Newas] After a months-long fight with Texas Medicaid over coverage of a gene therapy, Afghan refugees now have a chance to save their infant son. After initially balking, Texas officials have agreed to pay for the costly treatment, the boy’s family and his doctor told STAT.

[University of Florida] As a physician-scientist and cancer researcher at the University of Florida, Dr. Duane Mitchell, is providing hope for patients in an area where there is often little: treatment for malignant brain tumors.

[Nature] Neuralink, the company through which entrepreneur Elon Musk hopes to revolutionize brain–computer interfaces, has implanted a ‘brain-reading’ device into a person for the first time.

[Almirall S.A.] Almirall S.A. announced a strategic partnership with Microsoft to drive innovation and digital transformation, advance the research of medical solutions for dermatological diseases, and accelerate the digital transformation of the company.

[University of Arkansas] Kevin Murach, an assistant professor in the College of Education and Health Professions Department of Health, Human Performance and Recreation, has been awarded the 2024 Cell & Molecular Physiology Section New Investigator Award from the American Physiological Society.

[The Angiogenesis Foundation] The Angiogenesis Foundation announced that its Chief Executive Officer, President & Medical Director, and co-founder, Dr. William Li, has been chosen as the inaugural recipient of the Dr. Andrew von Eschenbach Award.